Doctors have said they didn’t expect him to live to see this day. But Monday marks a milestone: Johnson, 46, is the first of hundreds of cancer patients to see his case against agrochemical giant Monsanto go to trial.
Since then, hundreds more non-Hodgkin’s lymphoma patients have made similar claims, Johnson’s attorney, Timothy Litzenburg, said. He now represents “more than 2,000 non-Hodgkin’s lymphoma sufferers who used Roundup extensively,” he said.
Johnson, a father of two in California’s Bay Area, applied Roundup weed killer 20 to 30 times per year while working as a pest manager for a county school system, his attorney said.
And there’s a lot riding on this case, which could set a legal precedent for thousands of cases to follow.
Report on Roundup ingredient in dispute
The big questions at stake are whether Roundup can cause cancer and, if so, whether Monsanto failed to warn consumers about the product’s cancer risk.
“For the herbicide glyphosate, there was limited evidence of carcinogenicity in humans for non-Hodgkin lymphoma,” the report states.
“The evidence in humans is from studies of exposures, mostly agricultural, in the USA, Canada, and Sweden published since 2001. In addition, there is convincing evidence that glyphosate also can cause cancer in laboratory animals.”
“More than 800 scientific studies, the U.S. EPA (Environmental Protection Agency), the National Institutes of Health and regulators around the world have concluded that glyphosate is safe for use and does not cause cancer,” Scott Partridge, Monsanto’s vice president of strategy, said in a statement.
“We have empathy for anyone suffering from cancer, but the scientific evidence clearly shows that glyphosate was not the cause. We look forward to presenting this evidence to the court.”
Monsanto spokeswoman Charla Lord said regulatory authorities help ensure Roundup is safe.
“The safety of each labeled use of a pesticide formulation must be evaluated and approved by regulatory authorities before it is authorized for sale,” she has said.
Many more cases to follow
Johnson’s case — and hundreds of similar cases against Monsanto — have been filed in various state courts, Litzenburg said. Many other cases have been filed in federal multidistrict litigation, or MDL.
MDL is a procedure similar to class-action, in that it consolidates pre-trial proceedings for the sake of efficiency. But unlike a class-action lawsuit, each case within an MDL gets its own trial — with its own outcome.
In other words, one MDL plaintiff might get a large settlement, while another plaintiff might get nothing.
It’s not clear when future state or MDL trials will begin. One advantage of filing in state court — as Johnson did — instead of through MDL is that state courts might produce an outcome faster.
And in Johnson’s case, time is critical.
“Mr. Johnson is angry and is the most safety-oriented person I know,” his attorney said. “Right now, he is the bravest dude in America. Whatever happens with the trial and his health, his sons get to know that.”
CNN’s Theresa Waldrop contributed to this report.
more recommended stories
Live: Michael Cohen surrenders to the FBI
Michael Cohen is expected to plead.
States aim to stop internet release of 3D-printed gun plans
Interested in Gun Control? Add Gun.
Shanann Watts was to have a ‘gender reveal’ party Saturday
But the Colorado woman and her.
EPA’s response to Obama climate policy includes fewer restrictions on coal plants
The Environmental Protection Agency on Tuesday.
Colorado suspect says he killed wife after he saw her strangling daughter, affidavit says
Chris Watts said the couple’s other.
Man accused of killing pregnant wife, daughters says he walked in on wife strangling children: Police
A Colorado man accused of killing.
Pope on Pennsylvania abuse report: We abandoned the little ones
In an unusually blunt letter released.
South Koreans enter North to reunite with kin split by war
Interested in North Korea? Add North.
New York Times ‘stands behind’ its article after attacks by Trump
The New York Times is pushing.
US says conserving oil is no longer an economic imperative
Conserving oil is no longer an.